Back

Quantifying changes in the plasma proteome over time following left ventricular assist device implantation

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Chronic Heart Failure – Treatment Ventricular Assist Devices HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Christina Aquilante

University of Colorado Anschutz Medical Campus, Aurora (United States of America)

21 More presentations in this session

Presentation thumbnail
Comparison of therapeutic effects between urapidil and nitroglycerin for treatment of acute heart failure with hypertension and atrial fibrillation in elderly patients
Professor Q. Hua (Beijing, CN)
Presentation thumbnail
Obstacles to mineralocorticoid receptor antagonists in a community based heart failure population
Mrs H. Norberg (Umea, SE)
Abstract Slides
Presentation thumbnail
Prognostic value of diuretic dose in stable chronic heart failure
Doctor L. Lupi (Brescia, IT)
Abstract
Presentation thumbnail
Two-years outcome of patients with heart failure and severe left ventricular dysfunction treated with ivabradine and low doses of beta-blocker
Doctor F. Melillo (Milan, IT)
Abstract
Presentation thumbnail
Effectiveness of Sacubitril/Valsartan in real-life practice: experience of a single center
Doctor J. Neiva (Viana do Castelo, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Session
Which device might help your HFpEF patient?
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Session
Devices in acute heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources